TransMedics Group, Inc. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/72c1f183-fd7c-4809-80d5-de99d580dd38/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $108.6M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-067032 |
| FY 2024 | $37.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029104 |
| FY 2023 | $-28.7M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-021155 |
| FY 2022 | $-31.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-004652 |
| FY 2021 | $-39.4M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-008045 |
| FY 2020 | $-26.4M | 2019-12-29 – 2020-12-31 | evidence 0001564590-22-008045 |
| FY 2019 | $-29.6M | 2018-12-30 – 2019-12-28 | evidence 0001564590-20-011409 |
| FY 2018 | $-20.2M | 2017-12-31 – 2018-12-29 | evidence 0001564590-20-011409 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).